Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Pilulka Lekarny AS's Days Inventory or its related term are showing as below:
XPRA:PINK'
s Days Inventory Range Over the Past 10 Years
Min: 20.91 Med: 24.45 Max: 28.57
Current: 25.74
During the past 6 years, Pilulka Lekarny AS's highest Days Inventory was 28.57. The lowest was 20.91. And the median was 24.45.
XPRA:PINK's Days Inventory is ranked better than 54.34% of 495
companies
in the Healthcare Providers & Services industry
Industry Median: 29.45
vs XPRA:PINK: 25.74
Pilulka Lekarny AS's Days Inventory
stayed the same
from Jun. 2024 (0.00) to Dec. 2025 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Pilulka Lekarny AS's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.00.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pilulka Lekarny AS (XPRA:PINK) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Pilulka Lekarny AS's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pilulka Lekarny AS's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Pilulka Lekarny AS Days Inventory Related Terms
Pilulka Lekarny AS Days Inventory Historical Data
* Premium members only.
The historical data trend for Pilulka Lekarny AS's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pilulka Lekarny AS Days Inventory Competitor Comparison
For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pilulka Lekarny AS Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's Days Inventory distribution charts can be found below:
* The bar in red indicates where Pilulka Lekarny AS's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pilulka Lekarny AS (XPRA:PINK) has a Days Inventory of 0.00 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pilulka Lekarny AS and its competitors. Over the past decade, Pilulka Lekarny AS's Days Inventory has ranged from 20.91 to 28.57. According to the industry distribution chart, Pilulka Lekarny AS ranks #226 out of 495 companies in the Healthcare Providers & Services industry, placing it in the top 45.7%.
Is Pilulka Lekarny AS's Days Inventory too high?
Pilulka Lekarny AS's current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 20.91 to a high of 28.57. Based on the distribution chart, Pilulka Lekarny AS ranks #226 out of 495 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Pilulka Lekarny AS has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's Days Inventory compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Pilulka Lekarny AS ranks #226 out of 495 companies for Days Inventory. This puts Pilulka Lekarny AS in the upper half of its industry. The industry median Days Inventory is 29.45. Historically, Pilulka Lekarny AS's own Days Inventory has ranged from 20.91 to 28.57 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.45, based on 495 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pilulka Lekarny AS and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pilulka Lekarny AS's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč112.81, compared to a current price of Kč110.00 — trading 2.5% below its estimated fair value. The current Days Inventory is 0.00. Pilulka Lekarny AS's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current Days Inventory is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?
Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be undervalued.
The current stock price of Kč110.00 is trading 2.5% below its estimated GF Value™ of Kč112.81.
GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.
Key valuation signals for XPRA:PINK:
Days Inventory: 0.00
GF Value™: Kč112.81 vs. price of Kč110.00 (2.5% below fair value)
No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
57GF Score
Get the complete analysis for XPRA:PINK
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPRA:PINK has been successfully added to your 
